25.00

5.36% 1.50

Precipio Inc (PRPO)

Overview News Price History Financials Discussions Forecast Stock Split

Precipio Inc stock is traded at $25.00, with a volume of 42,042. It is up +5.36% in the last 24 hours and up +0.49% over the past month. Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Previous Close:

$23.50

Open:

$23.15

24h Volume:

42,042

Relative Volume:

0.61

Market Cap:

$43.93M

Revenue:

$25.83M

Net Income/Loss:

$-922.00K

P/E Ratio:

-48.46

EPS:

-0.5159

Net Cash Flow:

$555.00K

1W Performance:

+9.56%

1M Performance:

+0.49%

6M Performance:

+5.36%

1Y Performance:

+68.44%

1-Day Range:

$22.96

$26.75

1-Week Range:

$21.48

$26.75

52-Week Range:

$13.80

$33.63

Precipio Inc Stock (PRPO) Company Profile

Name

Precipio Inc

Sector

Healthcare (1089)

Industry

Diagnostics & Research (50)

Phone

203 787 7888

Address

4 SCIENCE PARK, NEW HAVEN, CT

Employee

Twitter

@precipiodx

Next Earnings Date

2026-08-17

Latest SEC Filings

PRPO's Discussions on Twitter

Compare PRPO vs TMO, DHR, NTRA, IDXX, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRPO Precipio Inc	24.58	42.00M	25.83M	-922.00K	555.00K	-0.5159
TMO Thermo Fisher Scientific Inc	586.36	217.52B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	201.92	142.32B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	312.82	44.67B	2.50B	-226.32M	71.51M	-1.6412
IDXX Idexx Laboratories Inc	543.29	43.41B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	148.72	41.95B	7.23B	1.41B	1.09B	4.979

Precipio Inc Stock (PRPO) Latest News

04:20 AM

Is Precipio Inc (PRPO) Overvalued Despite Q2 Revenue of $7M? GF Score: 51/100, Valuation Discrepancy of 118.4% - GuruFocus

Aug 14, 2026

Precipio Posts Record Quarterly Revenue, Returns to Positive Adjusted EBITDA - Minichart

Aug 14, 2026

Form 8K Precipio Inc For: 14 August By Investing.com - Investing.com Australia

Aug 14, 2026

Precipio Q2 Revenue Hits Record $7.0 Million, Up 22% Year Over Year - Quiver Quantitative

Aug 14, 2026

Precipio posts record Q2 revenue $7.0M, returns to positive Adjusted EBITDA - TradingView

Aug 14, 2026

Precipio (PRPO) hits record Q2 revenue above $7M and returns to positive Adjusted EBITDA - Stock Titan

Aug 14, 2026

Precipio Q2 Results: EPS turns to loss of $(0.12), sales up 24% - scanx.trade

Aug 14, 2026

Precipio, Inc. 2026: Revenue $7.02M, EPS ($0.12) — 10-Q Summary - TradingView

Aug 14, 2026

Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive - TradingView

Aug 14, 2026